The Aminosteroid Phospholipase C Antagonist U-73122 (1-[6-[[17-β-3-Methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione) Potently Inhibits Human 5-Lipoxygenase in Vivo and in Vitro
- Address correspondence to:
Dr. Oliver Werz, Institute of Pharmaceutical Chemistry, University of Frankfurt, Marie-Curie Strasse 9, D-60439 Frankfurt, Germany. E-mail: o.werz{at}pharmchem.uni-frankfurt.de
Abstract
U-73122 (1-[6-[[17-β-3-methoxyestra-1,3,5(10)-trien-17-yl]amino] hexyl]-1H-pyrrole-2,5-dione) is a widely used antagonist of phosphoinositide-specific phospholipase C (PLC) and is frequently used to define a role of PLC in receptor-mediated elevation of intracellular calcium concentration ([Ca2+]i). In human polymorphonuclear leukocytes (PMNLs), U-73122 inhibited increases in [Ca2+]i induced by G protein-coupled receptor (GPCR) agonists (N-formyl-methionyl-leucyl-phenylalanine or platelet-activating factor; IC50 of ≈2 to 4 μM), but it failed to suppress responses induced by ionomycin or thapsigargin. 5-Lipoxygenase (5-LO) is a Ca2+-regulated enzyme that can be activated in leukocytes by stimuli that elevate [Ca2+]i. Attempts to investigate the involvement of PLC in cellular 5-LO activation revealed that U-73122 suppresses 5-LO product synthesis regardless of the stimulus and independently of Ca2+. Thus, U-73122 blocked 5-LO product synthesis induced by cell stress, involving 5-LO phosphorylation pathways in the absence of Ca2+ with an IC50 of ≈2 μM. Direct inhibition of 5-LO by U-73122 was evident in PMNL homogenates (IC50 of ≈2.4 μM), and isolated human recombinant 5-LO enzyme was potently inhibited by U-73122 (IC50 of ≈30 nM). Thiols (glutathione) strongly blunted the effect of U-73122 on isolated 5-LO. On the other hand, depletion of cellular thiols by N-ethylmaleimide strongly increased the efficacy of U-73122 to inhibit 5-LO in intact cells or corresponding homogenates, suggesting that U-73122 may interfere with sulfhydryl groups on 5-LO. Since 5-LO products induce increases in [Ca2+]i via GPCRs, caution should be used when interpreting data where U-73122 is used as tool to determine a direct role of PLC in receptor-mediated Ca2+ mobilization.
Footnotes
-
This study was supported by the European Union (LEUCHRON, QLRT-2000-01521), the Deutsche Forschungsgemeinschaft (GRK 137/3), and the Deutsche Pharmazeutische Gesellschaft.
-
Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.
-
doi:10.1124/mol.105.011007.
-
ABBREVIATIONS: U-73122, 1-[6-[[17-β-3-methoxyestra-1,3,5(10)-trien-17-yl] amino]hexyl]-1H-pyrrole-2,5-dione; PLC, phospholipase C; PIP2, phosphatidylinositol bisphosphate; DAG, diacylglycerol; IP3, inositol 1,4,5-trisphosphate; LO, lipoxygenase; LT, leukotriene; MAPK, mitogen-activated protein kinase; GPCR, G protein-coupled receptor; [Ca2+]i, intracellular calcium concentration; U-73343, 1-[6-[[17β-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-2,5-pyrrolidine-dione; AA, arachidonic acid; fMLP, N-formyl-methionyl-leucyl-phenylalanine; GSH, glutathione; NEM, N-ethylmaleimide; PAF, platelet-activating factor; HPLC, high-performance liquid chromatography; PMNL, polymorphonuclear leukocyte; PBS, phosphate-buffered saline; RT, room temperature; DMSO, dimethyl sulfoxide; BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid; AM, acetoxymethyl ester.
-
- Received January 6, 2005.
- Accepted January 31, 2005.
- The American Society for Pharmacology and Experimental Therapeutics



